Active Ingredient: DALFAMPRIDINE
Proprietary Name: DALFAMPRIDINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A206646
Product Number: 001
Approval Date: Oct 24, 2018
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information